Page not found
Search results
-
Taking a bite out of Charcot-Marie-Tooth Disease
... mom saying I wasn’t like the other kids.” A genetic test in January 2006 at Washington University in St. Louis led to a diagnosis ... manager of corporate alliances for Vanderbilt’s Center for Technology Transfer and Commercialization, attended a global conference ...
sommers - 03/18/2024 - 1:36pm
-
Rethinking drug efficacy: research aims to improve drug development
... Postdoctoral Fellow in 2023, are developing a startup with technology that will allow drug developers to test the impact of pharmacokinetic profiles on drug responses. “Beyond ...
sommers - 03/11/2024 - 8:54am
-
Potential schizophrenia treatment, discovered at Vanderbilt and being developed by Neumora Therapeutics, entering Phase 1 clinical trial
... demonstrated a favorable pharmacologic profile that includes high potency and selectivity for the M4 receptor subtype, meriting its ... collaboration was facilitated by the Center for Technology Transfer and Commercialization . Vanderbilt researchers who ...
sommers - 01/17/2024 - 10:08am
-
Vanderbilt highlights smart mobility research, innovative solutions at Nashville expo
... University) Diermeier will introduce the “Test it in Tennessee” panel, focusing on leveraging the state’s technology platforms, like the I-24 Motion testbed and Chattanooga’s ...
sommers - 12/05/2023 - 1:07pm
-
Vanderbilt engineering professor’s company makes successful first-in-human clinical study using novel device for endoscopic surgery
... first-in-human clinical study using its innovative technology that radically improves minimally invasive endoscopic surgery. ... not be possible, and has the potential to eliminate the risk of infection from reusable duodenoscopes,” said Dr. Keith Obstein, ...
sommers - 08/07/2023 - 9:33am
-
Team explores diabetes drug’s ability to treat RSV infection
... tract infection and bronchiolitis. The RSV strain induced high levels of inflammatory factors and airway mucus in mice, conditions that ... RSV bronchiolitis is the No. 1 cause of hospitalization for infants in the United States, with up to 125,000 children hospitalized each ...
sommers - 07/13/2018 - 9:56am
-
‘Friendly’ bacteria may impact COVID severity
... IMGSCT (Immunogenomics, Microbial Genetics and Single Cell Technology) cores, is co-investigator. Key resources include BioVU , ... for several years. In 2018, they reported that infants who have higher amounts of the “friendly” bacterium ...
sommers - 03/16/2021 - 8:18am
-
“Ultra-potent” antibody against COVID-19 variants isolated at VUMC
09/27/2021 A technology developed at Vanderbilt University Medical Center has led to the ... Education ( ACCRE ), Georgiev put Setliff’s idea to the test. It worked. The efforts led by Setliff and Shiakolas culminated in a ...
sommers - 09/28/2021 - 9:45am
-
Discovery Vanderbilt invests in three faculty-initiated startups: HeroWear, IDBiologics and Virtuoso
... the Center for Rehabilitation Engineering and Assistive Technology by Karl Zelik , associate professor of mechanical ... vaccines in protecting vulnerable populations—the elderly, infants or immunocompromised—from HIV or cancer. The company was founded in ...
sommers - 05/23/2023 - 12:14pm
-
LaunchTN, Vanderbilt partner to support innovation, commercialization of Tennessee-based technologies
... will work collaboratively to support, engage and attract high-growth startups. They will also seek to bring more innovative solutions to market with increased activities around technology transfer and commercialization. Vanderbilt, a world-renowned ...
sommers - 05/11/2023 - 9:10am